Suchergebnisse

AbstractChildren in foster care are a remarkably heterogeneous group regarding their adaptation, and disrupted emotion understanding is one of the processes that may lead to differential outcomes in them. Previous research has found different effects for abused and for neglected children in emotion recognition. However, very few studies have analysed more complex forms of emotion understanding in maltreated children while considering different adversity dimensions. The present study analysed associations between threat and deprivation exposure and different facets of emotion understanding in a sample of maltreated children in foster care. The sample comprised 51 children from 4 to 9 years old (M = 7.07, SD = 1.63) in nonkin foster care in Spain. We used the Test of Emotional Comprehension to measure emotion understanding and maltreatment reports to measure exposure to threat and deprivation. Threat exposure predicted enhanced external emotion understanding after controlling for age, vocabulary, and deprivation, particularly understanding emotions based on desires. Deprivation predicted worse external emotion understanding. Our findings reinforce the limits of cumulative risks models for understanding foster children's developmental outcomes and the value of assessing separately adversity dimensions when possible, given the variable relations of threat and deprivation exposure with social cognitive development.

El objetivo de este estudio es analizar las características de los anticoagulantes orales directos (DOACs) y determinar cuál de ellos es el más adecuado según las características clínicas de cada paciente; para ello, se realizó una búsqueda exhaustiva en MEDLINE a través de la base de datos PUBMED, utilizando términos como "DOACs", "tratamiento de la FA con DOACs", "tratamiento antitrombótico de la fibrilación auricular", "anticoagulantes orales directos", "dabigatrán", "rivaroxabán" y "apixabán". Los resultados obtenidos revelaron que los DOACs reducen la tasa de sangrado en pacientes que requieren anticoagulación, y el apixabán mostró la menor tasa de sangrado y complicaciones cardiovasculares. En conclusión, se requiere un análisis riguroso para determinar el DOAC más adecuado en cada caso.